GOODBODY SECURITIES INC X-17A-5 (2026-02-27) — Broker-dealer annual report

Full text of GOODBODY SECURITIES INC's X-17A-5 filed 2026-02-27 (period 2025-12-31). Broker-dealer annual report from SEC EDGAR — readable, searchable, and available as markdown for AI agents.

Document text (excerpt)

{0}------------------------------------------------ # **GOODBODY SECURITIES INCORPORATED** ## **STATEMENT OF FINANCIAL CONDITION AND REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM** **DECEMBER 3l8t, 2025** {1}------------------------------------------------ # **TABLE OF CONTENTS** **FACING PAGE** **OATH OR AFFIRMATION** **REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM** ... • .. I • **STATEMENT OF FINANCIAL CONDITION** **NOTES TO THE FINANCIAL STATEMENTS** {2}------------------------------------------------ | | | | 0MB APPROVAL | | |----------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------|----------------------------------------|--------------------------------------------------------|-------| | SECURITIES AND EXCHANGE COMMISSION | | | 0MB Number: 3235-0123 | | | Washington, D.C. 20549 | | | Expires: November 30, 2026<br>Estimated average burden | | | | | | hours per response | 12.00 | | | ANNUAL AUDITED REPORT | | | | | FORM X-17A-5<br>PART Ill | | | SEC FILE NUMBER | | | | | | | | | | | | 8-66955 | | | | FACING PAGE<br>Information Required Pursuant to Rules 17a-5, 17a-12, and 18a-7 under the Securities Exchange Act of 1934 | | | | | | | | | | | REPORT FOR THE PERIOD BEGINNING | 01/01/2025 AND EN DING ___ ---=1=2'-"/3=1,_,/2=02==5 ____ _ | | | | | | MM/DD/YY | MM/DD/YY | | | | | A.<br>REGISTRANT IDENTIFICATION | | | | | NAME OF FIRM: Goodbody Securities Incorporated<br>TYPE OF REGISTRANT (check all applicable boxes): | | | | | | 181 Broker-dealer | □Security-based swap dealer | □Major security-based swap participant | | | | 0 Check here if respondent is also an OTC derivatives dealer | | | | | | | | | | | | ADDRESS OF PRINCIPAL PLACE OF BUSINESS: (Do not use P.O. Box No.) | | | | | | 9 -12 Dawson St, Dublin 2, D02 YX99 | | | | | | | (No. and Street) | | | | | Dublin | Dublin 4 | | Ireland | | | (City) | (State} | | (Zip Code) | | | PERSON TO CONTACT WITH REGARD TO THIS FILING | | | | | | Ian Huggard +353 1 6419243 | | ian.h uggard@goodbody.ie | | | | | | | | | | \Name) | l�rnailAd<lre»)<br>(Area Code-Ttlephone Number) | | | | | | | | | | | | B, ACCOUNTANT IDENTIFICATION | | | | | IN DEPENDENT PUBLIC ACCOUNTANT whose opinion is contained in this Report• | | | | | | DeMarco, Sciaccotta, Wilkens & Dunleavy, LLP | | | | | | | (Name - if individual, state last, first, middle nam…

Read the full text as markdown

Other filings by this registrant

Original filing on SEC EDGAR (source of record)